A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
Clinical trial NCT04677959 · COMPLETED
Trial details
- NCT number
- NCT04677959
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2022-03-04
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.